Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for prevention of ovarian hyperstimulation syndrome
IRCT138806181141N6Phase 3Completed
- Sponsor
- Royan Institute
- Start
- Oct 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylprednisolone in ovarian hyperstimulation syndrome (OHSS), sponsored by Royan Institute. Started Oct 2009; status: completed.
02
Drugs
methylprednisolone
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on IRCT138806181141N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138806181141N6.